Tayo Adekiya to Praziquantel
This is a "connection" page, showing publications Tayo Adekiya has written about Praziquantel.
Connection Strength
2.003
-
Adekiya TA, Kumar P, Kondiah PPD, Ubanako P, Choonara YE. In Vivo Evaluation of Praziquantel-Loaded Solid Lipid Nanoparticles against S. mansoni Infection in Preclinical Murine Models. Int J Mol Sci. 2022 Aug 22; 23(16).
Score: 0.861
-
Adekiya TA, Kumar P, Kondiah PPD, Pillay V, Choonara YE. Synthesis and therapeutic delivery approaches for praziquantel: a patent review (2010-present). Expert Opin Ther Pat. 2021 Sep; 31(9):851-865.
Score: 0.784
-
Adekiya TA, Aruleba RT, Klein A, Fadaka AO. In silico inhibition of SGTP4 as a therapeutic target for the treatment of schistosomiasis. J Biomol Struct Dyn. 2022 05; 40(8):3697-3705.
Score: 0.191
-
Aruleba RT, Adekiya TA, Oyinloye BE, Masamba P, Mbatha LS, Pretorius A, Kappo AP. PZQ Therapy: How Close are we in the Development of Effective Alternative Anti-schistosomal Drugs? Infect Disord Drug Targets. 2019; 19(4):337-349.
Score: 0.167